Valuation: Mayinglong Pharmaceutical Group Co., LTD.

Market Cap 1.06TCr 158.28Cr 140.7Cr 130.41Cr 118.65Cr 223.89Cr 15TCr 227.48Cr 1.57TCr 614.59Cr 7.84TCr 594.03Cr 581.39Cr 25TCr P/E 2026 *
15.9x
P/E 2027 * 14.3x
Enterprise Value 1.06TCr 158.28Cr 140.7Cr 130.41Cr 118.65Cr 223.89Cr 15TCr 227.48Cr 1.57TCr 614.59Cr 7.84TCr 594.03Cr 581.39Cr 25TCr EV / Sales 2026 *
2.52x
EV / Sales 2027 * 2.3x
Free-Float
64.65%
Yield 2026 *
-
Yield 2027 * -
1 day+0.70%
1 week+7.06%
Current month+9.10%
1 month+9.54%
3 months+3.71%
6 months-0.77%
Current year-12.25%
1 week 22.9
Extreme 22.9
24.98
1 month 22.12
Extreme 22.12
24.98
Current year 21.22
Extreme 21.22
29.22
1 year 21.22
Extreme 21.22
30.18
3 years 20.2
Extreme 20.2
31.46
5 years 17.99
Extreme 17.99
32.2
10 years 12.52
Extreme 12.52
33.54
Manager TitleAgeSince
Chief Executive Officer 48 28/05/2019
Director of Finance/CFO 49 28/12/2023
Corporate Officer/Principal 40 19/08/2021
Director TitleAgeSince
Chairman 64 16/03/2010
Director/Board Member 48 28/05/2019
Director/Board Member 40 14/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
+0.70%+7.06%-13.49%+9.25% 158.28Cr
+0.43%+6.59%+56.57%+106.64% 1,12000Cr
+0.90%-2.25%+32.26%+63.73% 62TCr
+0.71%+3.24%+24.33%+91.33% 50TCr
-0.13%+5.98%+33.66%+50.18% 37TCr
+0.52%+0.24%+72.13%+40.11% 36TCr
-0.95%+4.70%+19.65%+42.71% 29TCr
-1.98%+3.73%-0.89%+10.43% 26TCr
-0.35%+4.25%+44.74%+52.06% 23TCr
-0.75%+3.32%+27.18%+94.07% 19TCr
Average -0.09%+3.67%+29.62%+56.05% 39.42TCr
Weighted average by Cap. +0.13%+3.83%+39.31%+71.80%

Financials

2026 *2027 *
Net sales 419.85Cr 63Cr 56Cr 52Cr 47Cr 89Cr 5.96TCr 90Cr 621.4Cr 243.64Cr 3.11TCr 235.49Cr 230.47Cr 9.91TCr 460.55Cr 69Cr 61Cr 57Cr 52Cr 97Cr 6.53TCr 99Cr 681.64Cr 267.26Cr 3.41TCr 258.32Cr 252.82Cr 11TCr
Net income 67Cr 9.98Cr 8.87Cr 8.22Cr 7.48Cr 14Cr 946.78Cr 14Cr 99Cr 39Cr 494.06Cr 37Cr 37Cr 1.58TCr 74Cr 11Cr 9.82Cr 9.11Cr 8.28Cr 16Cr 1.05TCr 16Cr 109.45Cr 43Cr 547.36Cr 41Cr 41Cr 1.74TCr
Net Debt - -
Projected Income Statement - Annual - Mayinglong Pharmaceutical Group Co., LTD.
Logo Mayinglong Pharmaceutical Group Co., LTD.
Mayinglong Pharmaceutical Group Co Ltd is a China-based company mainly engaged in the production and sale of anorectal health products. The Company operates three segments. The Pharmaceutical Industry segment is mainly engaged in the development, production and sale of pharmaceuticals and health products. The Pharmaceutical Commerce segment is mainly engaged in the retail and wholesale of medical devices and pharmaceuticals. The Hospital Diagnosis and Treatment segment is mainly engaged in hospital medical services and management. The Company mainly conducts businesses within the domestic market.
Employees
2,544
Date Price Change Volume
16/26/16 CN¥24.57 +0.70% 78,64,179
15/26/15 CN¥24.40 -0.65% 96,86,415
14/26/14 CN¥24.56 +3.54% 1,15,89,960
13/26/13 CN¥23.72 +0.55% 82,12,280
12/26/12 CN¥23.59 +2.79% 72,76,758
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Mayinglong Pharmaceutical Group Co., LTD.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
24.57CNY
Average target price
37.74CNY
Spread / Average Target
+53.62%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Mayinglong Pharmaceutical Group Co., LTD.
  1. Stock Market
  2. Stocks
  3. 600993 Stock